Lack of cable pili expression by cblA-containing Burkholderia cepacia complex

Microbiology

Volumn 148, Issue 11, 2002, Pages 3477-3484

  Umadevi, Sajjan ^a   Liu, Lixia ^b   Spilker, Theodore ^a   Forstner, Janet ^a   LiPuma, John J ^b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Bacterial adherence; cblA gene; Cystic fibrosis

Indexed keywords

ADHESIN; BACTERIAL PROTEIN; CELL RECEPTOR; CYTOKERATIN; MEMBRANE PROTEIN; PILIN; PROTEIN CB1A; PROTEIN SUBUNIT; UNCLASSIFIED DRUG;

BACTERIAL STRAIN; BACTERIUM ADHERENCE; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM PILUS; BURKHOLDERIA CEPACIA; CANADA; CONTROLLED STUDY; CYSTIC FIBROSIS; ELECTRON MICROSCOPY; EPITHELIUM CELL; GENE EXPRESSION; HUMAN; MAJOR CLINICAL STUDY; MOLECULAR CLONING; MORBIDITY; MORPHOLOGY; MORTALITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; REVIEW; SEQUENCE ANALYSIS; SOUTHERN BLOTTING; SPUTUM CULTURE; UNITED KINGDOM; WESTERN BLOTTING;

ANIMALIA; BACTERIA (MICROORGANISMS); BURKHOLDERIA; BURKHOLDERIA CEPACIA; NEGIBACTERIA;

EID: 0041347879     PISSN: 13500872     EISSN: None     Source Type: Journal    
DOI: 10.1099/00221287-148-11-3477     Document Type: Review

References (29)

1. Auble, D. T., Allen, T. L. & DeHaseth, P. I. (1987). Promoter recognition by Escherichia coli RNA polymerase. Effects of substitutions in the spacer DNA separating the -10 and -35 regions. J Biol Chem 261, 11202-11206.
2. Chen, J. S., Witzmann, K., Spilker, T., Fink, R. & LiPuma, J. J. (2001). Endemicity and inter-city spread of Burkholderia cepacia genomovar III in cystic fibrosis. J Pediatr 139, 643-649.
3. Clode, F. E., Kaufmann, M. E., Malnick, H. & Pitt, T. L. (2000). Distribution of genes encoding putative transmissibility factors among epidemic and non-epidemic strains of Burkholderia cepacia from cystic fibrosis patients in the United Kingdom. J Clin Microbiol 38, 1763-1766.
4. Coenye, T., Vandamme, P., Govan, J. R. W. & LiPuma, J. J. (2001). Taxonomy and identification of the Burkholderia cepacia complex. J Clin Microbiol 39, 3427-3436.
5. Cravioto, A., Scotland, S. M. & Rowe, B. (1982). Hemagglutination activity and colonization factor antigens I and II in enterotoxigenic and non-enterotoxigenic strains of E. coli isolated from humans. Infect Immun 43, 508-514.
6. Franke, W. W., Schiller, D. L., Moll, R., Winter, E., Schmid, E., Engelbrecht, L., Denk, H., Kreplear, R. & Platzer, B. (1981). Diversity of cytokeratins. Differentiation specific expression of cytokeratin polypeptides in epithelial cells and tissues. J Mol Biol 153, 933-955.
7. Govan, J. R. W., Brown, P. H., Maddison, J., Doherty, C. J., Nelson, J. W., Dodd, Greening, A. P. & Webb, A. K. (1993). Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet 342, 15-19.
8. Hearst, J. E. & Elliott, K. E. (1995). Identifying the killer in cystic fibrosis. Nat Med 1, 626-627.
9. Johnson, W. M., Tyler, S. D. & Rozee, K. R. (1994). Linkage analysis of geographical and clinical clusters in Pseudomonas cepacia infections by multilocus enzyme electrophoresis and ribotyping. J Clin Microbiol 32, 924-930.
10. LiPuma, J. J. (1998). Burkholderia cepacia: management issues and new insights. Clin Chest Med 19, 473-486.
11. LiPuma, J. J. & Mahenthiralingam, E. (1999). Commercial use of Burkholderia cepacia. Emerg Infect Dis 5, 305-306.
12. LiPuma, J. J., Dulaney, B. J., McMenamin, J. D., Whitby, P. W., Stull, T. L., Coenye, T. & Vandamme, P. (1999). Development of rRNA-based PCR assays for identification of Burkholderia cepacia complex isolates recovered from cystic fibrosis patients. J Clin Microbiol 37, 3167-3170.
13. LiPuma, J. J., Spilker, T., Gill, L., Campbell, P. W., Liu, L. & Mahenthiralingam, E. (2001). Disproportionate distribution of Burkholderia cepacia complex species and transmissibility factors in cystic fibrosis. Am J Respir Crit Care Med 164, 92-96.
14. Mahenthiralingam, E., Simpson, D. A. & Speert, D. P. (1997). Identification and characterization of a novel DNA marker associated with epidemic Burkholderia cepacia strains recovered from patients with cystic fibrosis. J Clin Microbiol 35, 808-816.
15. Mahenthiralingam, E., Bischof, J., Byrne, S. K., Radomski, C., Davies, J. E., Av-Gay, Y. & Vandamme, P. (2000a). DNA-based diagnostic approaches for identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis, and Burkholderia cepacia genomovars I and III. J Clin Microbiol 38, 3165-3173.
16. Mahenthiralingam, E., Coenye, T, Chung, J. W., Speert, D. P., Govan, J. R., Taylor, P. & Vandamme, P. (2000b). Diagnostically and experimentally useful panel of strains from the Burkholderia cepacia complex. J Clin Microbiol 38, 910-913.
17. Parke, J. L. & Gurian-Sherman, D. (2001). Diversity of the Burkholderia cepacia complex and implications for risk assessment of biological control strains. Annu Rev Phytopathol 39, 225-258.
18. Pitt, T. L., Kaufmann, M. E., Patel, P. S., Benge, L. C., Gaskin, S. & Livermore, D. M. (1996). Type characterisation and antibiotic susceptibility of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis in the United Kingdom and the Republic of Ireland. J Med Microbiol 44, 203-210.
19. Richardson, J., Stead, D. E. & Coutts, R. H. A. (2001). Incidence of the cblA major subunit pilin gene amongst Burkholderia species. FEMS Microbiol Lett 196, 61-66.
20. Sajjan, U. S. & Forstner, J. F. (1992). Identification of the mucin-binding adhesin of Pseudomonas cepacia isolated from patients with cystic fibrosis. Infect Immun 60, 1434-1440.
21. Sajjan, U. S., Sun, L., Goldstein, R. & Forstner, J. F. (1995). Cable (cbl) type II pili of cystic fibrosis-associated Burkholderia (Pseudomonas) cepacia: nucleotide sequence of the cblA major subunit pilin gene and novel morphology of the assembled appendage fibers. J Bacteriol 177, 1030-1038.
22. Sajjan, U. S., Sylvester, F. A. & Forstner, J. (2000a). Cable-piliated Burkholderia cepacia binds to cytokeratin 13 of epithelial cells. Infect Immun 68, 1787-1795.
23. Sajjan, U., Wu, Y., Kent, G. & Forstner, J. (2000b). Preferential adherence of cable-piliated Burkholderia cepacia to respiratory epithelia of CF knockout mice and human cystic fibrosis lung explants. J Med Microbiol 49, 875-885.
24. Sajjan, U. S., Ackerly, C. & Forstner, J. (2002). Interaction of cblA adhesin positive Burkholderia cepacia with squamous epithelia. Cell Microbiol (in press).
25. Speert, D. P., Henry, D., Vandamme, P., Corey, M. & Mahenthiralingam, E. (2002). Epidemiology of Burkholderia cepacia complex inpatients with cystic fibrosis in Canada: geographical distribution and clustering of strains. Emerg Infect Dis 8, 181-187.
26. + Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and Britain. Nat Med 1, 661-666.
27. Tenover, F. C., Arbeit, R. D., Goering, R. V., Mickelsen, P. A., Murray, B. E., Persing, D. H. & Swaminathan, B. (1995). Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33, 2233-2239.
28. Whiteford, M. L., Wilkenson, J. D., McColl, J. H., Conoln, F. M., Michie, J. R., Evans, T. J. & Paton, J. Y. (1995). Outcome of Burkholderia (Pseudomonas) cepacia colonisation in children with cystic fibrosis following a hospital outbreak. Thorax 50, 1194-1198.
29. Wise, M. G., Shimkets, L. J. & McArthur, J. V. (1995). Genetic structure of a lotic population of Burkholderia (Pseudomonas) cepacia. Appl Environ Microbiol 61, 1791-1798.